Bionoid Pharma Inc. (BINP)

Bionoid Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Cash & Equivalents	0.03	0.08	-	0.98	0.15
Short-Term Investments	0	0	0	0.05	-
Cash & Short-Term Investments	0.03	0.09	0	1.03	0.15
Cash Growth	-67.76%	2193.59%	-99.63%	605.08%	330.63%
Accounts Receivable	0.01	-	-	-	-
Receivables	0.01	0.07	-	-	-
Inventory	0.06	-	-	-	-
Prepaid Expenses	-	-	-	-	0
Total Current Assets	0.09	0.15	0	1.03	0.15
Property, Plant & Equipment	0	0	0.01	0.01	0.01
Other Intangible Assets	0.04	-	-	0.28	0.31
Total Assets	0.14	0.16	0.01	1.33	0.47
Accounts Payable	0.3	0.31	0.4	0.4	0.34
Accrued Expenses	0.51	0.68	1.38	1.58	1.34
Short-Term Debt	0.38	0.15	0.06	0.22	0.18
Current Portion of Long-Term Debt	0.04	-	-	-	0.03
Other Current Liabilities	0.02	-	-	-	-
Total Current Liabilities	1.25	1.14	1.85	2.2	1.89
Long-Term Debt	0.03	-	-	-	-
Total Liabilities	1.28	1.14	1.85	2.2	1.89
Common Stock	0.01	0.01	0	0	0
Additional Paid-In Capital	19.01	17.55	16.82	13.92	9.59
Retained Earnings	-20.16	-18.54	-18.65	-14.67	-10.76
Comprehensive Income & Other	-	-	-0.02	-0.12	-0.26
Shareholders' Equity	-1.14	-0.98	-1.84	-0.87	-1.42
Total Liabilities & Equity	0.14	0.16	0.01	1.33	0.47
Total Debt	0.45	0.15	0.06	0.22	0.21
Net Cash (Debt)	-0.43	-0.07	-0.06	0.81	-0.06
Net Cash Per Share	-12.17	-3.78	-3.76	68.37	-
Filing Date Shares Outstanding	0.04	0.02	0.02	0.01	0.01
Total Common Shares Outstanding	0.04	0.02	0.02	0.01	0.01
Working Capital	-1.16	-0.99	-1.85	-1.17	-1.74
Book Value Per Share	-29.92	-47.06	-108.76	-59.32	-132.94
Tangible Book Value	-1.19	-0.98	-1.84	-1.16	-1.73
Tangible Book Value Per Share	-31.04	-47.06	-108.76	-78.68	-162.33
Machinery	-	-	-	-	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.